|
⚲
|
| Keyboard |
| Lloyd-Smith Malcolm
✚
|
|
|---|---|
| CIK # | 0001557146 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001557146] | |
| 4 | [0001557146] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Neurocrine Biosciences Inc | |
| Lloyd-Smith Malcolm | |
| Cadence Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2023-02-08 | Sell | 701 | $103.83 | 72,785 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2023-02-07 | Sell | 12,801 | $102.41 | 1,310,950 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2023-02-07 | Sell | 1,015 | $102.16 | 103,692 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2023-02-06 | Sell | 801 | $105.82 | 84,762 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2023-01-31 | Sell | 1,666 | $110.02 | 183,293 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-08-15 | Option exercise | 3,455 | $35.99 | 124,345 |
|
Neurocrine Biosciences Inc NBIX
Incentive Stock Option · derivative
|
2022-08-15 | Option exercise | 3,455 | $35.99 | 124,345 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-08-15 | Option exercise | 3,361 | $43.24 | 145,330 |
|
Neurocrine Biosciences Inc NBIX
Incentive Stock Option · derivative
|
2022-08-15 | Option exercise | 3,361 | $43.24 | 145,330 |
|
Neurocrine Biosciences Inc NBIX
Incentive Stock Option · derivative
|
2022-08-15 | Option exercise | 1,227 | $81.49 | 99,988 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-08-15 | Option exercise | 1,227 | $81.49 | 99,988 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2022-08-12 | Option exercise | 21,533 | $35.99 | 774,973 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-08-12 | Option exercise | 21,533 | $35.99 | 774,973 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-08-12 | Sell | 21,533 | $105.95 | 2,281,421 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-02-08 | Sell | 701 | $79.53 | 55,751 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-02-07 | Sell | 1,015 | $80.73 | 81,941 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-02-07 | Sell | 865 | $80.78 | 69,875 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2022-02-07 | Sell | 801 | $80.65 | 64,601 |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2022-01-31 | Grant | 21,546 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2022-01-31 | Grant | 3,164 | $0.00 | |
| showing 20 of 125 most recent transactions | |||||